Țară: Armenia
Limbă: engleză
Sursă: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
betamethasone (betamethasone dipropionate), salicylic acid
Cenexi HSC
D07XC
betamethasone (betamethasone dipropionate), salicylic acid
0,5mg/g+20mg/g
lotion
30ml plastic container-dropper
Prescription
Registered
2017-12-11
1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT DIPROSALIC ® 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _GENERAL CHARACTERISTIC: _ _MAIN PHYSICAL/CHEMICAL PROPERTIES_: a colourless, translucent, viscous solution, without foreign inclusion. Can be opalescence. _COMPOSITION: _ 1 g of lotion contains betamethasone 0.5 mg (as dipropionate) and salicylic acid 20 mg; _excipients: _ disodium edentate, hydroxypropyl methylcellulose, sodium hydroxide, isopropyl alcohol, purified water. 3. PHARMACEUTICAL FORM Lotion. PHARMACOTHERAPEUTIC GROUP. Dermatological corticosteroids. Active corticosteroids in combination with other agents. ATC code: D07X C01. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS To relieve inflammation in the psoriasis and seborrheic dermatitis of scalp, psoriasis of other sites and dermatoses that are normally responsive to corticosteroid therapy, except facial seborrheic dermatitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults and children: several drops of lotion should be applied to cover the affected areas and then be massaged gently into the skin or scalp. It is usually applied twice daily – in the morning and in the evening. _Duration of therapy_ . It is recommended that using of lotion 2 times daily should be limited to one-two weeks; for maintenance therapy application once daily may be adequate. Increased frequency of application the drug may aggravate side effects without increasing therapeutic efficacy. In some cases application of one dose daily is adequate. Frequency of application may be reduced after improvement of disease. Precautions should be taken if extensive body surface areas are treated (metering the used drug). Withdrawal should be done gradually, by increasing interval of dosing or using less strong or less dosed corticosteroids, or alternating to the drugs which are not containing corticosteroids. The period of application should not exceed three weeks. Long continuous treatment is not recommended to all patients, irrespective of age. The dru Citiți documentul complet